Regis HealthcareASX:REG -2.53%81 Debt-to-Equity is -75.74 as of Dec. 2025. GuruFocus rates ASX:REG with a GF Score™ of 81/100 and a GF Value™ of A$10.54 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 556 Healthcare Providers & Services companies, Regis Healthcare ranks worse than 179855.94% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Regis Healthcare's Debt-to-Equity or its related term are showing as below:
ASX:REG'
s Debt-to-Equity Range Over the Past 10 Years
Min: -75.74 Med: 1.55 Max: 16
Current: -75.74
During the past 11 years, the highest Debt-to-Equity Ratio of Regis Healthcare was 16.00. The lowest was -75.74. And the median was 1.55.
ASX:REG's Debt-to-Equity is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.4
vs ASX:REG: -75.74
Regis Healthcare (ASX:REG) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Regis Healthcare Debt-to-Equity Related Terms
Regis Healthcare Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Regis Healthcare's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:REG vs HCA, THC, DVA: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Regis Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regis Healthcare Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Regis Healthcare's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regis Healthcare (ASX:REG) has a Debt-to-Equity of -75.74 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Regis Healthcare and its competitors. According to the industry distribution chart, Regis Healthcare ranks #999999 out of 556 companies in the Healthcare Providers & Services industry.
Is Regis Healthcare's Debt-to-Equity too high?
Regis Healthcare's current Debt-to-Equity is -75.74. Based on the distribution chart, Regis Healthcare ranks #999999 out of 556 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Regis Healthcare has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Regis Healthcare ranks #999999 out of 556 companies for Debt-to-Equity. This places Regis Healthcare in the lower half of its industry. The industry median Debt-to-Equity is 0.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.40, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Regis Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regis Healthcare's current Debt-to-Equity is -75.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.54, compared to a current price of A$6.16 — trading 41.6% below its estimated fair value. The current Debt-to-Equity is -75.74. Regis Healthcare's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current Debt-to-Equity is -75.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regis Healthcare (ASX:REG) Overvalued in 2026?
Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued.
The current stock price of A$6.16 is trading 41.6% below its estimated GF Value™ of A$10.54.
GuruFocus considers Regis Healthcare to be Possible Value Trap.
Key valuation signals for ASX:REG:
Debt-to-Equity: -75.74
GF Value™: A$10.54 vs. price of A$6.16 (41.6% below fair value)
No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
81GF Score
Get the complete analysis for ASX:REG
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:REG has been successfully added to your 
